Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use

Antibiotic resistance in patients with cirrhosis continues to draw significant attention. With a propensity to frequent hospitalisations, patients with cirrhosis are subject to frequent antibiotic prescription. This increases their risk of developing resistance to one or more antimicrobial agents,...

Full description

Bibliographic Details

Main Authors:	Rooshi Nathwani, Benjamin Mullish, David Kockerling, Alexander Cole, Nowlan Selvapatt, Ameet Dhar
Format:	Artigo
Language:	Inglês
Published:	European Medical Journal 2021-09-01
Series:	European Medical Journal
Online Access:	https://www.emjreviews.com/hepatology/article/review-of-rifaximin-a-summary-of-the-current-evidence-and-benefits-beyond-licensed-use-j190321/
Tags:	Add Tag No Tags, Be the first to tag this record!